Danaher Corp (NYSE:DHR)
| 77.59 Delayed Data As of Sep 23 |  -0.08 / -0.10%Today’s Change | 61.58 Today|||52-Week Range 82.64 | +10.22% Year-to-Date |
DHR Regular Dividend: DHR will begin trading ex-dividend on 09/28/16 with a $0.125 dividend payable to shareholders of record as of 09/30/16.
Latest DHR News | Press Releases
| Serial acquirers: fools not suffered Sep 19 / FT.com - Paid Partner Content | Why GenMark Diagnostics, Inc. Is Soaring Today Sep 16 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 77.67 |
| Today’s open | 77.45 |
| Day’s range | 77.34 - 77.83 |
| Volume | 2,796,870 |
| Average volume (3 months) | 3,118,373 |
| Market cap | $53.6B |
| Dividend yield | 0.64% |
Data as of 4:05pm ET, 09/23/2016
Growth & Valuation
| Earnings growth (last year) | +1.06% |
| Earnings growth (this year) | -15.38% |
| Earnings growth (next 5 years) | +5.70% |
| Revenue growth (last year) | +3.26% |
| P/E ratio | 19.7 |
| Price/Sales | 3.20 |
| Price/Book | 2.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TMOThermo Fisher Scient... | 0.00 | 0.00% |
| AAgilent Technologies... | -0.06 | -0.13% |
| WATWaters Corp | -0.15 | -0.10% |
| MTDMettler-Toledo Inter... | -3.00 | -0.73% |
Data as of 4:02pm ET, 09/23/2016
Financials
| Next reporting date | October 13, 2016 |
| EPS forecast (this quarter) | $0.82 |
| Annual revenue (last year) | $20.6B |
| Annual profit (last year) | $2.6B |
| Net profit margin | 12.64% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Thomas Patrick Joyce |
Chief Financial Officer & Executive Vice President Daniel L. Comas |
Corporate headquarters Washington, District Of Columbia |
Forecasts
